Yamo Pharmaceuticals

0 followers

‌

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Headquarters

Stage

Employees

Links

Org chart

Chief Executive Officer

Chuck Bramlage

Collapse

Chief Financial Officer

Senior Vice President – Regulatory Affairs & Quality

Vice President Of Clinical Research Operations

AbbVie

149 followers

Novavax

7 followers

Amgen

179 followers

Bristol-Myers Squibb

163 followers

Thermo Fisher Scientific

140 followers

Genentech

142 followers

Gilead Sciences

119 followers

Biogen

107 followers

Regeneron

87 followers

Illumina

65 followers

Viatris

30 followers

Discover companies